Launch of ENMC Mid-Career Mentoring Programme

One of the key pillars of the NMD4C is to empower and support our neuromuscular early-career members to help them grow as future thought leaders, innovators, and experts in the neuromuscular community. Although the NMD4C is a network that exists to serve the Canadian NM community, we believe that an important part of research progress consists of collaboration and learning on a global scale.

 

The European Neuromuscular Centre (ENMC) is a worldwide network whose mission is to establish international collaboration of experts in the world, to facilitate the establishment of consortia and to foster basic research and treatment development for patients with a neuromuscular condition.

 

The ENMC has long been involved in efforts to support junior researchers and clinicians in establishing a network in the NM community through their Early-Career Programme (formerly known as the Young Scientist Programme). In 2020, the ENMC identified a need for a specific leadership programme in the NMD field for strongly motivated scientists and clinicians, who already have a proven track record in neuromuscular science.

Building from the success of the ENMC Early-Career Programme, the ENMC is proud to launch a new and ambitious Mid-Career Mentoring Programme.

This programme is conceived to support and prepare talented and committed neuromuscular specialists for transdisciplinary, cooperative leadership, thereby promoting innovation and progress of future neuromuscular research. These individuals will be at the stage in their careers where they are developing their own research plans and are establishing their own teams and collaborative networks, have already completed their PhD and one or more post-doc positions. Scope of the mentoring programme is to empower these mid-career professionals and prepare them for independent leadership, most importantly increasing their chances of reaching high positions where they have the possibility to open up tenure-track perspectives for the next generations.

 

The NMD4C are excited to share that three of our Investigators will be participating in this programme as mentors, and we encourage any of our mid-career members who are interested in this programme to apply as mentees before the July 1st deadline!

 

Read more about the criteria for becoming a successful ENMC Mentee candidate here: Guidelines – ENMC.

 

For our early-career members, the ENMC also continues to provide an opportunity for younger members of the NMD research and clinical community to participate in ENMC workshops through their Early-Career Programme.

This programme helps junior researchers connect with established scientists and clinicians in the neuromuscular field and gives them a chance to obtain state-of-the art knowledge on research topics. The Early-Career Programme allows predominantly PhD students, post-docs and early-career clinicians to participate in ENMC workshops of their choice where they listen, present their research, discuss and report on the workshop outcomes.

 

 

With the birth of the Mid-Career Mentoring Programme and the continuation of the Early-Career programme, the ENMC provides learning support to the entire spectrum of rising stars in the neuromuscular field, from PhD students to research group leader/clinical unit heads.

 

More information about the ENMC programmes for early- and mid-career researchers, can be found on the ENMC website (www.enmc.org).

About the ENMC from Anymazed on Vimeo.

 

 

ENMC logo topkwaliteit

Read next...

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted. 

MDC award $900 000 towards clinical and translational research projects in 2024.

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.

SMA outcome measures training graphic

SMA Outcome Measures Training for Physiotherapists and Occupational Therapists

To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.

Congratulations to the 2024 early career award winners. Dr Mireille Khacho and Dr Jean-Philippe Leduc Gaudet.

Congratulations to the 2024 NMD4C Early Career Awards Recipients

We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.